PRKD1 and cardiac hypertrophy: The resulting hydrolysate, diacylglycerol (DAG), activates the hypertrophic pathway by promoting the activation of nuclear protein kinase D (PKD) and inhibiting myocardial hypertrophy considerably when mAKAPβ is depleted (Zhang et al., 2013; Vergarajauregu et al., 2020).